Evidence map›Paper›PMID 39232006›Full record

ArticleNature communications2024

Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional remodeling and reelin secretion.

D Stephen Serafin, Natalie R Harris, László Bálint, Elizabeth S Douglas, Kathleen M Caron

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Metabolic Syndrome-Driven Changes in Cardiac Lymphatic Endothelium: mRNA Expression and Emerging Questions.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

D Stephen Serafin *Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, 111 Mason Farm Road, Chapel Hill, 27599, NC, USA.ORCID 0000-0003-1104-305X
Natalie R Harris *Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, 111 Mason Farm Road, Chapel Hill, 27599, NC, USA.ORCID 0000-0002-6405-4230
László BálintDepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, 111 Mason Farm Road, Chapel Hill, 27599, NC, USA.ORCID 0000-0002-3142-4071
Elizabeth S DouglasDepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, 111 Mason Farm Road, Chapel Hill, 27599, NC, USA.ORCID 0000-0002-6749-7838
Kathleen M CaronDepartment of Cell Biology and Physiology, University of North Carolina at Chapel Hill, 111 Mason Farm Road, Chapel Hill, 27599, NC, USA. kathleen_caron@med.unc.edu.ORCID 0000-0002-7033-9232

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
CANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0M
Adrenomedullin Signaling at the Maternal-Fetal InterfaceR01HD060860 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kathleen M Caron · 2009 to 2026
$4.8M
Cardiac Lymphatics in Heart FailureR01HL129086 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, KATHLEEN M · 2016 to 2023
$4.1M
GPCR-mediated pathways for regulation of intestinal lymphatic functionR01DK119145 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, KATHLEEN M · 2019 to 2023
$2.6M
Adrenomedullin Signaling in Vascular DevelopmentR01HL091973 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, KATHLEEN M · 2008 to 2011
$1.4M
Elucidating the GPCR protein networks that drive lymphatic growthF31HL163885 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERAFIN, DONALD STEPHEN · 2022 to 2024
$126k
NCI NIH HHS P30 CA016086NCI NIH HHS T32 CA071341NHLBI NIH HHS F31 HL163885NHLBI NIH HHS R01 HL091973NHLBI NIH HHS R01 HL129086NHLBI NIH HHS T32 HL069768NICHD NIH HHS R01 HD060860NIDDK NIH HHS R01 DK119145U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 5 R01HD060860-08U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 5 R01HL091973-04U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) 5 R01DK119145-05
6 · The paper itself

Abstract

The adhesion receptor vascular endothelial (VE)-cadherin transduces an array of signals that modulate crucial lymphatic cell behaviors including permeability and cytoskeletal remodeling. Consequently, VE-cadherin must interact with a multitude of intracellular proteins to exert these functions. Yet, the full protein interactome of VE-cadherin in endothelial cells remains a mystery. Here, we use proximity proteomics to illuminate how the VE-cadherin interactome changes during junctional reorganization from dis-continuous to continuous junctions, triggered by the lymphangiogenic factor adrenomedullin. These analyses identified interactors that reveal roles for ADP ribosylation factor 6 (ARF6) and the exocyst complex in VE-cadherin trafficking and recycling. We also identify a requisite role for VE-cadherin in the in vitro and in vivo control of secretion of reelin-a lymphangiocrine glycoprotein with recently appreciated roles in governing heart development and injury repair. This VE-cadherin protein interactome shines light on mechanisms that control adherens junction remodeling and secretion from lymphatic endothelial cells.

Indexed as

Adherens JunctionsAntigens, CDCadherinsEndothelial CellsReelin ProteinADP-Ribosylation Factor 6ADP-Ribosylation FactorsAnimalsCadherin 5Cell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsHumansIntercellular JunctionsMiceNerve Tissue ProteinsProtein TransportADP-Ribosylation Factor 6ADP-Ribosylation FactorsAntigens, CDCadherin 5CadherinsCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsNerve Tissue ProteinsReelin ProteinRELN protein, humanReln protein, mouseSerine Endopeptidases

Identifiers

PMID39232006
PMCPMC11374903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.